• Loading...
    Contact Us

    Birth Defects Epidemiology & Surveillance
    Mail Code 1964
    P.O. Box 149347
    Austin, TX 78714-9347

    Phone: 512-776-7232
    Fax: 512-776-7330

    Email comments or questions



Birth Defects Risk Factor Series

Click here for an Adobe PDF version of this document. (180KB PDF, Viewing Information)

NEW: Please take a moment to evaluate our birth defects risk factor series. Click here to take survey.


Conotruncal heart defects are also known as outflow tract defects. Common types of conotruncal heart defects are truncus arteriosus, transposition of the great arteries, double outlet of the right ventricle, and tetralogy of Fallot. In truncus arteriosus, also known as common truncus, there is a single outflow tract instead of a separate aorta and pulmonary artery. Transposition of the great arteries consists of the great arteries being switched so that the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta originate from the right ventricle. Tetralogy of Fallot involves a ventricular septal defect, right ventricular outflow tract obstruction such as pulmonary atresia or stenosis, aorta overriding the ventricular septum, and right ventricular hypertrophy. Common truncus often occurs with interrupted aortic arch (Pradat 2003). Other types of conotruncal defects include pulmonary atresia with ventricular septal defect and aortopulmonary window.


A portion of conotruncal heart defects are associated with chromosomal abnormalities such as trisomy 21, trisomy 13, and trisomy 18 (Harris 2003, Boldt 2002, Garne 1999, Tennstedt1999, Torfs 1998, Ferencz 1997, Kallen 1996, O’Malley 1996, Pradat 1992, Ferencz 1989). About 6% of patients with conotruncal defects have 22q11 microdeletion syndrome (Beauchesne 2005). In particular, truncus arteriosus and tetralogy of Fallot may occur with the chromosome 22q microdeletion linked to DiGeorge syndrome and velocardiofacial syndrome (Boudjemline 2002, Kessler-Icekson 2002, Boudjemline 2001, Cuneo 2001, Driscoll 2001, Marino 2001, Maeda 2000, Borgmann 1999, Lu 1999, Trost 1999, Goldmuntz 1998, Ferencz 1997, Ryan 1997, Webber 1996, Takahashi 1995). Cases of tetralogy of Fallot associated with severe pulmonary artery anomalies, extracardiac anomalies, increased nuchal translucency, polyhydramnios, intrauterine growth retardation were more likely to have 22q11 deletion (Boudjemline 2002). In addition, hypoparathyroidism with 22q11 deletion has been associated with extended regression of the 4th aortic arch, but not outflow tract malformations (Koch 2002).

Approximately 4% of nonsyndromic cases of tetralogy of Fallot may have mutations in the transcription factor NKX2.5 (Goldmuntz 2001). Two mutations in the CFC1 gene have also be found in patients with transposition of the great arteries and double outlet right ventricle (Goldmuntz 2002), and mutations in the F2, F7, NPPA, and ITGB3 genes carry a higher risk for offspring with conotruncal defects (combined). (Shaw 2005).

Over the last several decades, ultrasonography and fetal echocardiography have allowed conotruncal defects to be identified in utero (Boudjemline 2001, Hafner 1998, Kirk 1997, Stoll 1997). In regions where elective termination is allowed, prenatal diagnosis and elective termination may reduce the birth prevalence of conotruncal defects (Boldt 2002, Garne 2001, Riley 1998, Stoll 1995, Stoll 1993, Stoll 1992).


Investigations into the relationship between conotruncal defects and race/ethnicity have been mixed. Various studies found higher rates among whites and Hispanics than African-Americans for transposition of the great arteries, tetralogy of Fallot, and truncus arteriosus (Botto 2001a, O’Malley 1996, Fixler 1993, Correa-Villasenor 1991), although in one study the difference was influenced by socioeconomic status (Correa-Villasenor 1991). Native Americans have higher rates of transposition of the great arteries and double outlet of the right ventricle than whites (O’Malley 1996). One investigation reported transposition of the great arteries to occur more frequently among whites than among non-whites (Adams 1989) or non-Hispanic whites compared to Hispanics (Pradat 2003). Pradat et al. (2003) also demonstrated higher rates of tetralogy of Fallot compared among blacks when with Hispanics, yet other studies reported no relationship between race/ethnicity and tetralogy of Fallot and truncus arteriosus (Shaw 2002, Storch 1992, Adams 1989) and conotruncal defects (Ferencz 1997).

Several studies have reported secular trends for conotruncal defects, with increasing rates over time for tetralogy of Fallot and double outlet right ventricle (Botto 2001a), conotruncal defects with normally related great arteries (Ferencz 1997), tetralogy of Fallot (Adams 1989), and transposition of the great arteries and tetralogy of Fallot (Grech 1998, Francannet 1993). However, in one study the increase was possibly due to increased ascertainment (Grech 1998) and in another the increase was only observed in several birth defects registries (Francannet 1993). Still another study reported little variation in rates of transposition of the great arteries and tetralogy of Fallot and greater variation in truncus arteriosus rates over time (Wren et al., 2000). One investigation observed seasonal variation, with higher rates of conotruncal defects among July-December deliveries (Ferencz 1997), while other studies identified no seasonal variation in rates of transposition of the great arteries or conotruncal defects as a group (Tikkanen 1991, Tikkanen 1990, Bound 1989). A study in Czechoslovakia reported seasonal differences in rates of transposition of the great arteries and tetralogy of Fallot (Samanek 1991a).

One study identified no relationship between geographic variation and transposition of the great arteries, while conotruncal defects with normally positioned great arteries (tetralogy of Fallot, truncus arteriosus, and some types of double outlet of the right ventricle) were more common in urban areas (Ferencz 1997). Another investigation found no geographic differences between conotruncal defect cases and controls (Tikkanen 1992a). A study in Czechoslovakia reported regional differences in rates of transposition of the great arteries, tetralogy of Fallot, and truncus arteriosus (Samanek 1991b).

Maternal age does not appear to influence risk of conotruncal defects, particularly transposition of the great arteries and tetralogy of Fallot (O’Malley 1996, Francannet 1993, Tikkanen 1992a, Tikkanen 1990, Baird 1991). However, one investigation observed increased risk of transposition of the great arteries with increasing maternal age (Rothman 1976). One study observed that risk of conotruncal defects was higher with paternal age greater than 30 years (O’Malley 1996). Several investigations noted increasing parity to increase risk of transposition of the great arteries, tetralogy of Fallot, and hypoplastic left heart syndrome taken as a group (Francannet 1993, Rothman 1976), and Pradat et al. (2003) found higher risk for mothers with 2 or more children for transposition of the great arteries and lower risk for tetralogy of Fallot. Other studies found no association between conotruncal defects and parity (O’Malley 1996, Adams 1989). Rates of transposition of the great arteries and tetralogy of Fallot have been found to be lower with maternal birthplace in Mexico than when the mother was born in the United States (O’Malley 1996).

With respect to sex, transposition of the great arteries, double outlet of the right ventricle, and tetralogy of Fallot are more common among males than females, while truncus arteriosus is more common among females or demonstrates no differences between the sexes (Pradat 2003, Lary 2001, Grech 2000, Garne 1999, Riley 1998, Ferencz 1997, O’Malley 1996, Samanek 1994, Sampayo 1994, Francannet 1993, Pradat 1992, Storch 1992, Fyler 1980, Rothman 1976).

Lower birth weight and gestational age is associated with increased risk of tetralogy of Fallot, double outlet of the right ventricle, and truncus arteriosus, although the relationship between birth weight and gestational age and transposition of the great arteries is less clear (Rasmussen 2001, Riley 1998, Ferencz 1997, Francannet 1993, Mili 1991, Rosenthal 1991). There is no relationship between conotruncal defects and macrosomia (Lapunzina 2002, Waller 2001). Transposition of the great arteries, tetralogy of Fallot, and truncus arteriosus have been associated with intrauterine growth retardation (Khoury 1988).

Several studies failed to identify any association between plurality and conotruncal defects (Ferencz 1997, O’Malley 1996, Doyle 1991). However, other studies reported increased rates of particular types of conotruncal defects among multiple gestations (Mastroiacovo 1999, Riley 1998, O’Malley 1996, Francannet 1993, Layde 1980).

Consanguinity has not been found to influence risk of conotruncal defects (Becker 2001, Rittler 2001).


The effects of socio-economic status (SES) and risk for conotruncal defects are variable; one study found that women of lower SES were more likely to have babies with transposition of the great arteries, but less likely for their offspring to have tetralogy of Fallot (Carmichael 2003).

Maternal occupation in clerical, sales, or factory fields increases risk of conotruncal defects with normally related great arteries (Ferencz 1997, Adams 1989) and paternal occupation of policeman or guard associated with transposition of the great arteries (Chia 2002). An investigation noted that maternal psychosocial or emotional stress (death, job loss, relationship breakup) may increase risk of conotruncal defects (Carmichael 2000, Adams 1989).

One study failed to identify any relationship between paternal exposures and conotruncal defects (Correa-Villasenor 1993). In contrast, another investigation identified associations between paternal X-rays and general anesthesia and tetralogy of Fallot and between marijuana and cocaine and transposition of the great arteries with intact ventricular septum (Ferencz 1997).

Increased risk of conotruncal defects has been reported with maternal exposure to dyes, lacquers, or paints at work, but not with organic solvents, disinfectants, pesticides, wood preservatives, anesthetic gases, glues, plastic raw materials, dust, video display terminals, or microwave ovens (Tikkanen 1992a, Tikkanen 1992b, Tikkanen 1990). However, another investigation found no association between conotruncal defects and parental pesticide exposure with the exception of maternal gardening pesticide exposure and insect repellent use (Shaw 1999). An additional study reported increased risk of transposition of the great arteries with maternal exposure to herbicides and rodenticides but not insecticides; other conotruncal defects were not associated with pesticides (Loffredo 2001a).

One study that examined the relationship between ambient air pollution and conotruncal defects found risk of the cardiac defects increased with second-month ozone exposure (Ritz 2002). No association was found with carbon monoxide, nitrogen dioxide, and PM10. Another investigation reported no relationship between the trihalomethanes, which are water disinfection byproducts, and conotruncal defects (Shaw 1991).

Association between between maternal alcohol use and conotruncal defects is none (Tikkanen 1992, Tikkanen 1990, Adams 1989) to moderate (Carmichael 2003). Higher rates of transposition of the great arteries have been reported with maternal smoking (Kallen 1999, Ferencz 1997), and higher rates were found among mothers with a variant of the NOS3 gene and perinatal cigarette smoking for conotruncal defects combined (Shaw 2005). However, other investigations noted that maternal smoking, coffee, tea, cocoa, and marijuana or hashish did not affect risk of conotruncal defects (Wasserman 1996, Tikkanen 1992, Adams 1989). One study reported higher rates of transposition of the great arteries and conotruncal defects when both parents smoked tobacco (Wasserman 1996).

Several studies had identified aspirin to increase risk of transposition of the great arteries (Zierler 1985, Heinonen 1977); however, a subsequent investigation failed to verify this association (Werler 1989). Bendectin has not been linked to conotruncal defects, while tetracycline has been reported to increase risk of transposition of the great arteries and codeine to increase risk of double outlet of the right ventricle (Adams 1989, Zierler 1985). An investigation reported increased risk of transposition of the great arteries with maternal anticonvulsant use, although exposure was reported for only one case (Correy 1991). Analyses have reported associations between benzodiazepines (Valium, Librium, Serax) and conotruncal defects (Ferencz 1997, Adams 1989) and ibuprofen and transposition of the great arteries, progesterone and transposition of the great arteries and truncus arteriosus, solvents and transposition of the great arteries and double outlet of the right ventricle, and ionizing radiation and transposition of the great arteries (Ferencz 1997). General anesthesia, tranquilizers, contraceptives, and Clomid do not appear to influence conotruncal defect rates ( Adams 1989). Maternal use of ampicillin during pregnancy does not appear to be associated with risk of truncus arteriosus, transposition of the great arteries, or tetralogy of Fallot (Czeizel 2001).

Maternal diabetes elevates risk of conotruncal defects (Loffredo 2001b, Ferencz 1997, Ramos-Arroyo 1992, Becerra 1990, Ferencz 1990, Adams 1989), although one study failed to find that association (Harris 2003). Associations between maternal influenza, thyroid disease (hyperthyroidism, hypothyroidism), and urinary tract or kidney infection and conotruncal defects have been inconsistent (Ferencz 1997, Adams 1989, Khoury 1989). One investigation found no statistically significant association between maternal febrile illness during early pregnancy and transposition of the great arteries or tetralogy of Fallot (Botto 2001b). Untreated maternal phenylkentonuria does not appear to increase risk of conotruncal defects (Levy 2001). One investigation reported no relationship between conotruncal defects and such long-term maternal illnesses as asthma, fever, nonrheumatoid heart disease, and epilepsy ( Adams 1989). Maternal upper respiratory infection has been associated with increased conotruncal defect risk (Tikkanen 1992, Tikkanen 1991, Tikkanen 1990). Obesity has been found to increase risk of defects of the great vessels (Waller 1994).

Various studies have reported a reduction in conotruncal defect rates with maternal multivitamin use (Botto 2000, Botto 1996, Shaw 1995, Czeizel 1993). One study observed increased risk of cardiac outflow trace defects and maternal fever and no multivitamin use; however, risk was reduced with multivitamin use (Botto 2002). In addition, there is evidence that certain mutations of a folate-related gene (MTHFR) in infants increases their likelihood of having omphalocele (van Beynum 2006). However, several studies failed to identify a reduction in conotruncal defect risk and multivitamins or folic acid (Werler 1999, Scanlon 1998), or heart defects in general (Bower 2006), nor did it reduce the risk of conotruncal defects among children with Down syndrome (Meijer 2006). One investigation reported increased risk of transposition of the great arteries with maternal supplementation of 10,000 IU or more of vitamin A (Botto 2001c). Another study noted no increased risk of transposition of the great arteries if the infant had the 677TT genotype of the methylenetetrahydrofolate reductase (MTHFR) gene (Junker 2001).


Prevalence of conotruncal heart defects per 10,000 live births


Texas (95% Confidence Interval) (Texas Department of State Health Services 2006)

United States (95% Confidence Interval) (Canfield 2006)

Common Truncus

0.89 (0.75-1.02)

0.82 (0.71-0.93)

Transposition of the Great Arteries

4.87 (4.55-5.19)

4.73 (4.46-5.00)

Tetralogy of Fallot

3.35 (3.09-3.62)

3.92 (3.67-4.17)

Double Outlet Right Ventricle



(Botto 2001a, O’Malley 1996, Ferencz 1985, Fyler 1980)


  • Adams MM, Mulinare J, Dooley K. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol 1989;14:432-442.
  • Baird PA, Sadovnick AD, Yee IM. Maternal age and birth defects: a population study. Lancet 1991;337:527-530.
  • Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Grogan M, Jalal SM, Michels VV. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults withselected conotruncal anomalies. J Am Coll Cardiol. 2005 Feb 15;45(4):595-8.
  • Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990;85:1-9.
  • Becker SM, Al Halees Z, Molina C, Paterson RM. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet 2001;99:8-13.
  • Boldt T, Andersson S, Eronen M. Outcome of structural heart disease diagnosed in utero. Scand Cardiovasc J 2002;36:73-79.
  • Borgmann S, Luhmer I, Arslan-Kirchner M, Kallfelz HC, Schmidtke J. A search for chromosome 22q11.2 deletions in a series of 176 consecutively catheterized patients with congenital heart disease: no evidence for deletions in non-syndromic patients. Eur J Pediatr 1999;158:958-963.
  • Botto LD, Erickson JD, Mulinare J, Lynberg MC, Liu Y. Maternal Fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology 2002;13:485-488.
  • Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001a;107:e32.
  • Botto LD, Lynberg MC, Erickson JD. Congenital heart defects, maternal febrile illness, and multivitamin use: a population-based study. Epidemiology 2001b;12:485-490.
  • Botto LD, Loffredo C, Scanlon KS, Ferencz C, Khoury MJ, David Wilson P, Correa A. Vitamin A and cardiac outflow tract defects. Epidemiology 2001c;12:491-496.
  • Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 2000;151:878-884.
  • Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;98:911-917.
  • Boudjemline Y, Fermont L, Le Bidois J, Lyonnet S, Sidi D, Bonnet D. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: A 6-year prospective study. J Pediatr 2001;138:520-524.
  • Boudjemline Y, Fermont L, Le Bidois J, Villain E, Sidi D, Bonnet D. Can we predict 22q11 status of fetuses with tetralogy of Fallot? Prenat Diagn. 2002;22:231-234.
  • Bound JP, Harvey PW, Francis BJ. Seasonal prevalence of major congenital malformations in the Fylde of Lancashire 1957-1981. J Epidemiol Community Health 1989;43:330-342.
  • Bower C, Miller M, Payne J, Serna P. Folate intake and the primary prevention of non-neural birth defects. Aust N Z J Public Health. 2006 Jun;30(3):258-61.
  • Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, Devine O, Petrini J, Ramadhani TA, Hobbs CA, Kirby RS. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol. 2006 Nov;76(11):747-56.
  • Carmichael SL, Shaw GM. Maternal life event stress and congenital anomalies. Epidemiology 2000;11:30-35.
  • Carmichael SL, Nelson V, Shaw GM, Wasserman CR, Croen LA. Socio-economic status and risk of conotruncal heart defects and orofacial clefts. Paediatr Perinat Epidemiol. 2003 Jul;17(3):264-71.
  • Carmichael SL, Shaw GM, Yang W, Lammer EJ. Maternal periconceptional alcohol consumption and risk for conotruncal heart defects. Birth Defects Res A Clin Mol Teratol. 2003 Oct;67(10):875-8.
  • Chia SE, Shi LM. Review of recent epidemiological studies on paternal occupations and birth defects. Occup Environ Med. 2002;59:149-155.
  • Correa-Villasenor A, Ferencz C, Loffredo C, Magee C. Paternal exposures and cardiovascular malformations. J Expo Anal Environ Epidemiol 1993;3 Suppl 1:173-185.
  • Correa-Villasenor A, McCarter R, Downing J, Ferencz C. White-black differences in cardiovascular malformations in infancy and socioeconomic factors. Am J Epidemiol 1991;134:393-402.
  • Correy JF, Newman NM, Collins JA, Burrows EA, Burrows RF, Curran JT. Use of prescription drugs in the first trimester and congenital malformations. Aust N Z J Obstet Gynaecol 1991;31:340-344.
  • Cuneo BF. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr 2001;13:465-472.
  • Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993;306:1645-1648.
  • Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 2001;185:140-147.
  • Doyle PE, Beral V, Botting B, Wale CJ. Congenital malformations in twins in England and Wales. J Epidemiol Community Health 1991;45:43-48.
  • Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genetics in Medicine 2001;3:14-18.
  • Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD, eds. Malformations of the cardiac outflow tract. In: Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Fuytura Publishing Co., Inc; 1997: pp. 59-102.
  • Ferencz C, Rubin JD, McCarter RJ, Clark EB. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 1990;41:319-326.
  • Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW. Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr 1989;114:79-86.
  • Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, Hepner SI, Downing JW. Congenital heart disease: prevalence at livebirth. Am J Epidemiol 1985;121:31-36.
  • Fixler DE, Pastor P, Sigman E, Eifler CW. Ethnicity and socioeconomic status: Impact on the diagnosis of congenital heart disease. J Am Coll Cardiol 1993;21:1722-1726.
  • Francannet C, Lancaster PA, Pradat P, Cocchi G, Stoll C. The epidemiology of three serious cardiac defects. A joint study between five centres. Eur J Epidemiol 1993;9:607-616.
  • Fyler DC. Report f the New England Regional Infant Cardiac Program. Pediatrics 1980;65:375-461.
  • Garne E, EUROCAT Working Group. Prenatal diagnosis of six major cardiac malformations in Europe--a population based study. Acta Obstet Gynecol Scand 2001;80:224-228.
  • Garne E, Nielsen G, Hansen OK, Emmertsen K. Tetralogy of Fallot. A population-based study of epidemiology, associated malformations and survival in western Denmark 1984-1992. Scand Cardiovasc J 1999;33:45-48.
  • Goldmuntz E, Bamford R, Karkera JD, dela Cruz J, Roessler E, Muenke M. CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet 2002;70:776-780.
  • Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation 2001;104:2565-2568.
  • Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, McDonald-McGinn D, Chien P, Feuer J, Zackai EH, Emanuel BS, Driscoll DA. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998;32:492-498.
  • Grech V. An excess of tetralogy of Fallot in Malta. J Epidemiol Community Health 1998;52:280-282.
  • Grech V. Diagnostic and interventional trends in tetralogy of Fallot and transposition of the great arteries in a population-based study. Pediatr Cardiol 2000;21:368-73.
  • Hafner E, Scholler J, Schuchter K, Sterniste W, Philipp K. Detection of fetal congenital heart disease in a low-risk population. Prenat diagn 1998;18:808-815.
  • Harris JA, Francannet C, Pradat P, Robert E. The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003 May-Jun;24(3):222-35. Epub 2003 Mar 17.
  • Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, Massachusetts: Publishing Sciences Group. 1977.
  • Junker R, Kotthoff S, Vielhaber H, Halimeh S, Kosch A, Koch HG, Kassenbohmer R, Heineking B, Nowak-Gottl U. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001;51:251-254.
  • Kallen B, Mastroiacovo P, Robert E. Major congenital malformations in Down syndrome. Am J Med Genet 1996;65:160-166.
  • Kallen K. Maternal smoking and congenital heart defects. Eur J Epidemiol 1999;15:731-737.
  • Kessler-Icekson G, Birk E, Weintraub AY, Barhum Y, Kotlyar V, Schlesinger H, Rockah R, Vidne BA, Frisch A. Association of Tetralogy of Fallot with a distinct region of del22q11.2. Am J Med Genet 2002;107:294-298.
  • Khoury MJ, Becerra JE, d'Almada PJ. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. Paediatr Perinat Epidemiol 1989;3:402-420.
  • Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: a population study. Pediatrics 1988;82:83-90.
  • Kirk JS, Comstock CH, Lee W, Smith RS, Riggs TW, Weinhouse E. Sonographic screening to detect fetal cardiac anomalies: A 5-year experience with 111 abnormal cases. Obstet Gynecol 1997;89:227-232.
  • Koch A, Hofbeck M, Buheitel G, Dorr HG, Rauch A, Rauch R, Singer H. Hypoparathyroidism in conotruncal heart defects. Eur J Pediatr. 2002 Apr;161(4):208-11.
  • Lapunzina P, Lopez Camelo JS, Rittler M, Castilla EE. Risks of congenital anomalies in large for gestational age infants. J Pediatr 2002;140:200-204.
  • Lary JM, Paulozzi LJ. Sex differences in the prevalence of human birth defects: a population-based study. Teratology 2001;64:237-251.
  • Layde PM, Erickson JD, Falek A, McCarthy BJ. Congenital malformation in twins. Am J Hum Genet 1980;32:69-78.
  • Levy HL, Guldberg P, Guttler F, Hanley WB, Matalon R, Rouse BM, Trefz F, Azen C, Allred EN, de la Cruz F, Koch R. Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study. Pediatr Res 2001;49:636-642.
  • Loffredo CA, Silbergeld EK, Ferencz C, Zhang J. Association of transposition of the great arteries in infants with maternal exposures to herbicides and rodenticides. Am J Epidemiol 2001a;153:529-536.
  • Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: An independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 2001b;64:98-106.
  • Lu JH, Chung MY, Hwang B, Chien HP. Prevalence and parental origin in Tetralogy of Fallot associated with chromosome 22q11 microdeletion. Pediatrics 1999;104:87-90.
  • Maeda J, Yamagishi H, Matsuoka R, Ishihara J, Tokumura M, Fukushima H, Ueda H, Takahashi E, Yoshiba S, Kojima Y. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet 2000;92:269-272.
  • Marino B, Digilio MC, Toscano A, Anaclerio S, Giannotti A, Feltri C, de Ioris MA, Angioni A, Dallapiccola B. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genetics in Medicine 2001;3:45-48.
  • Mastroiacovo P, Castilla EE, Arpino C, Botting B, Cocchi G, Goujard J, Marinacci C, Merlob P, Metneki J, Mutchinick O, Ritvanen A, Rosano A. Congenital malformations in twins: an international study. Am J Med Genet 1999;83:117-124.
  • Meijer WM, Werler MM, Louik C, Hernandez-Diaz S, de Jong-van den Berg LT, Mitchell AA. Can folic acid protect against congenital heart defects in Down syndrome? Birth Defects Res A Clin Mol Teratol. 2006 Oct;76(10):714-7.
  • Mili F, Edmonds LD, Khoury MJ, McClearn AB. Prevalence of birth defects among low-birth-weight infants. A population study. Am J Dis Child 1991;145:1313-1318.
  • Montana E, Khoury MJ, Cragan JD, Sharma S, Dhar P, Fyfe D. Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J Am Coll Cardiol 1996;28:1805-1809.
  • O’Malley CD, Shaw GM, Wasserman CR, Lammer EJ. Epidemiologic characteristics of conotruncal heart defects in California, 1987-1988. Teratology 1996;53:374-377.
  • Pradat P. Epidemiology of major congenital heart defects in Sweden, 1981-1986. J Epidemiol Community Health 1992;46:211-215.
  • Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003 May-Jun;24(3):195-221. Epub 2003 Mar 14.
  • Ramos-Arroyo MA, Rodriguez-Pinilla E, Cordero JF. Maternal diabetes: the risk for specific birth defects. Eur J Epidemiol 1992;8:503-508.
  • Rasmussen SA, Moore CA, Paulozzi LJ, Rhodenhiser EP. Risk for birth defects among premature infants: A population-based study. J Pediatr 2001;138:668-673.
  • Riley MM, Halliday JL, Lumley JM. Congenital malformations in Victoria, Australia, 1983-95: an overview of infant characteristics. J Paediatr Child Health 1998;34:233-240.
  • Rittler M, Liascovich R, Lopez-Camelo J, Castilla EE. Parental consanguinity in specific types of congenital anomalies. Am J Med Genet 2001;102:36-43.
  • Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA. Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol 2002;155:17-25.
  • Rosenthal GL, Wilson PD, Permutt T, Boughman JA, Ferencz C. Birth weight and cardiovascular malformations: a population-based study. Am J Epidemiol 1991;133:1273-1281.
  • Rothman KJ, Fyler DC. Sex, birth order, and maternal age characteristics of infants with congenital heart defects. Am J Epidemiol 1976;104:527-534.
  • Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brondum-Nielsen K, Stewart F, Van Essen T, Patton M, Paterson J, Scambler PJ. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997;34:798-804.
  • Samanek M. Boy:girl ratio in children born with different forms of cardiac malformation: a population-based study. Pediatr Cardiol 1994;15:53-57.
  • Samanek M, Slavik Z, Krejcir M. Seasonal differences in the incidence of congenital heart defects. Czech Med 1991a;14:146-155.
  • Samanek M, Slavik Z, Balatka J, Bartakova H, Goetzova J, Homola J, Rusava I, Smrcka J, Krejcir M. Krajove rozdily vyskytu vrozenych srdecnich vad. Cesk Pediatr 1991b;46:65-70.
  • Sampayo F, Pinto FF. Distribuicao por sexos das cardiopatias congenitas. Acta Med Port 1994;7:413-418.
  • Scanlon KS, Ferencz C, Loffredo CA, Wilson PD, Correa-Villasenor A, Khoury MJ, Willett WC. Preconceptional folate intake and malformations of the cardiac outflow tract. Epidemiology 1998;9:95-98.
  • Shaw GM, Carmichael SL, Nelson V. Congenital malformations in offspring of Vietnamese women in California, 1985-97. Teratology 2002;65:121-124.
  • Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, Lammer EJ. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A. 2005 Sep 15;138(1):21-6.
  • Shaw GM, Wasserman CR, O'Malley CD, Nelson V, Jackson RJ. Maternal pesticide exposure from multiple sources and selected congenital anomalies. Epidemiology 1999;10:60-66.
  • Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995;59:536-545.
  • Shaw GM, Malcoe LH, Milea A, Swan SH. Chlorinated water exposures and congenital cardiac anomalies. Epidemiology 1991;2:459-460.
  • Stoll C, Alembik Y, Dott B, De Geeter B, Meyer MJ, Peter PO, Pennerath A. Evaluation of prenatal diagnosis of congenital heart disease. Teratology 1997;55:49.
  • Stoll C, EUROCAT Working Group. Distribution of single organ malformations in European populations. Ann Genet 1995;38:32-43.
  • Stoll C, Dott B, Alembik Y, Roth MP. Evaluation of routine prenatal diagnosis by a registry of congenital anomalies. Prenat Diagn 1995;15:791-800.
  • Stoll C, Alembik Y, Dott B, Roth PM, De Geeter B. Evaluation of prenatal diagnosis of congenital heart disease. Prenat Diagn 1993;13:453-461.
  • Stoll C, Alembik Y, Dott B, Roth MP, Finck S. Evaluation of prenatal diagnosis by a registry of congenital anomalies. Prenat Diagn 1992;12:263-270.
  • Storch TG, Mannick EE. Epidemiology of congenital heart disease in Louisiana: an association between race and sex and the prevalence of specific cardiac malformations. Teratology 1992;46:271-276.
  • Takahashi K, Kido S, Hoshino K, Ogawa K, Ohashi H, Fukushima Y. Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr 1995;154:878-881.
  • Tennstedt C, Chaoui R, Korner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 1999;82:34-39.
  • Texas Department of State Health Services. Texas birth defects registry report of birth defects among 1999-2003 deliveries. 2006.
  • Tikkanen J, Heinonen OP. Risk factors for cardiovascular malformations in Finland. Eur J Epidemiol 1990;6:348-356.
  • Tikkanen J, Heinonen OP. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring. Eur J Epidemiol 1991;7:628-635.
  • Tikkanen J, Heinonen OP. Risk factors for conal malformations of the heart. Eur J Epidemiol 1992a;8:48-57.
  • Tikkanen J, Heinonen OP. Occupational risk factors for congenital heart disease. Int Arch Occup Environ Health 1992b;64:59-64.
  • Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet 1998;77:431-438.
  • Trost D, Engels H, Bauriedel G, Wiebe W, Schwanitz G. Angeborene kardiovaskulare Fehlbildungen und chromosomale mikrodeletionen in 22q11.2. Dtsch Med Wochenschr 1999;124:3-7.
  • van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniëls O, Blom HJ. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J. 2006 Apr;27(8):981-7. Epub 2006 Mar 7.
  • Waller DK, Mills JL, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Rhoads GG. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 1994;170:541-548.
  • Waller DK, Keddie AM, Canfield MA, Scheuerle AE. Do infants with major congenital anomalies have an excess of macrosomia? Teratology 2001;64:311-317.
  • Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 1996;53:261-267.
  • Webber SA, Hatchwell E, Barber JC, Daubeney PE, Crolla JA, Salmon AP, Keeton BR, Temple IK, Dennis NR. Importance of microdeletions of chromosomal region 22q11 as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-year prospective study. J Pediatr 1996;129:26-32.
  • Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 1999;150:675-682.
  • Werler MM, Mitchell AA, Shapiro S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989;321:1639-1642.
  • Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 2000;83(4):414-419.
  • Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 1985;313:347-352.

Please Note: The primary purpose of this report is to provide background necessary for conducting cluster investigations. It summarizes literature about risk factors associated with this defect. The strengths and limitations of each reference were not critically examined prior to inclusion in this report. Consumers and professionals using this information are advised to consult the references given for more in-depth information. 

This report is for information purposes only and is not intended to diagnose, cure, mitigate, treat, or prevent disease or other conditions and is not intended to provide a determination or assessment of the state of health. Individuals affected by this condition should consult their physician and when appropriate, seek genetic counseling.

For more information:

Birth Defects Epidemiology and Surveillance
Texas Department of State Health Services
1100 W. 49th Street, Austin, Texas 78756
512-776-7232 Fax 512-776-7330

Document E58-10957                      Revised August 2007

Return to Birth Defects Risk Factor Page

Last updated February 10, 2012